Equivalence between preexposure schemes for human rabies and evaluation of the need for serological monitoring

Revista de Saude Publica

Volumn 44, Issue 3, 2010, Pages 548-554

  Cunha, Ricardo Siqueira ^a   da Silva, Andréa de Cássia Rodrigues ^a   Batista, Alexandre Mendes ^a   Chaves, Luciana Botelho ^a   Barata, Rita Barradas ^b  

^a Secretaria de Estado da Saude de Sao Paulo   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Humoral; Immunology.Serology.Immunity; Intervention studies.Rabies; Prevention control; Rabies vaccines

Indexed keywords

RABIES VACCINE; VIRUS ANTIBODY;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; RABIES; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; RABIES; RABIES VACCINES;

EID: 77955364596     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102010005000005     Document Type: Article

References (21)

1. Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ. 2000;78(5):693-8.
2. Briggs DJ, Schwenke JR. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine. 1992;10(2):125-9. DOI:10.1016/0264-410X(92)90029-J.
3. Burridge MJ, Baer GM, Sumner JW, Sussman O. Intradermal immunization with human diploid cell rabies vaccine: serological and clinical responses of persons with and without prior vaccination with duck embryo vaccine. JAMA 1982;248(13):1611-4. DOI:10.1001/jama.248.13.1611.
4. Chulasugandha P, Khawplod P, Havanond P, Wilde H. Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children. Vaccine. 2006;24(9):1478-82. DOI:10.1016/j. vaccine.2005.03.059.
5. Hulley SB Cummings SR,Browner WS, Grady DG, Newman TB. Delineando a pesquisa clinica: uma abordagem epidemiológica. 2.ed. Porto Alegre: Artmed; 2003.
6. Kositprapa C, Limsuwun K, Wilde H, Jaijaroensup W, Saikasem A, Khawplod P, et al. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations. Clin Infect Dis. 1997;25(3):614-6. DOI:10.1086/513760.
7. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-15):1-48.
8. Errata em: MMWR Morb Mortal Wkly Rep. 2006;55(48):1303.
9. Malerczyk C, Briggs DJ, Dreesen DW, Banzhoff A. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine. J Travel Med. 2007;14(1):63-4. DOI:10.1111/j.1708-8305.2006.00097.x.
10. Moore SE, Goldblatt D, Bates CJ, Prentice AM. Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children. Acta Paediatr. 2003;92(2):170-6.
11. Pancharoen C, Thisyakorn U, Tantawichien T, Jaijaroensup W, Khawplod P, Wilde H. Failure of pre- and postexposure rabies vaccinations in a child infected with HIV. Scand J Infect Dis. 2001;33(5):390-1. DOI:10.1080/003655401750174183.
12. Rupprecht CE, Gibbons RV. Clinical practice. Prophylaxis against rabies. New Eng J Med. 2004;351(25):2626-35. DOI:10.1056/NEJMcp042140.
13. Sabchareon A, Chantavanich P, Pasuralertsakul S, Pojjaroen-Anant C, Prarinyanupharb V, Attanath P, et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J. 1998;17(11):1001-7. DOI:10.1097/00006454-199811000-00007.
14. Shaw MM, Leggat PA, Williams ML. Intradermal preexposure rabies immunisation in New Zealand. Travel Med Infect Dis. 2006;4(1):29-33. DOI:10.1016/j.tmaid.2004.11.005.
15. Siegel S. Estatística não-paramétrica: para as ciências do comportamento. Rio de Janeiro: McGraw-Hill; 1975.
16. Smith JS, Yager PA, Baer GM. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virusneutralizing antibody. In: Meslin FX, Kaplan MM, Koprowski H. Laboratory techniques in rabies. 4.ed. Geneva: World Health Organization; 1996. p.181-92.
17. Strady A, Lang J, Lienard M, Blondeau C, Jaussaud R, Plotkin SA. Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis. 1998;177(5):1290-5. DOI:10.1086/515267.
18. Strady C, Jaussaud R, Béguinot I, Lienard M, Strady A. Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy. Vaccine. 2000;18(24):2661-7. DOI:10.1016/S0264-410X(00)00054-2.
19. Toovey S. Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience. Travel Med Infect Dis. 2007;5(6):327-48. DOI:10.1016/j.tmaid.2007.07.004.
20. Wilde H, Briggs DJ, Meslin FX, Hemachudha T, Sitprija V. Rabies update for travel medicine advisors. Clin Infect Dis. 2003;37(1):96-100. DOI:10.1086/375605.
21. World Health Organization. WHO expert consultation on rabies: first report. Geneva; 2005 [citado 2008 set 10]. (WHO technical report series, 931). Disponível em: http://www.who.int/rabies/trs931_%2006_05.pdf.